Quarterly Results, Broker Conferences, Special IR Events FY2018 (April 2018-March 2019)

FY2018 Full Year Results (released on May 14th, 2019)

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor’s report)
Click to download

Press Release

Pipeline Supplemental
Click to download


Earnings Release Presentation

For Media
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer, and others
Click to download

 

For Investors and Analysts
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Andrew Plump, President, Research & Development
Costa Saroukos, Chief Financial Officer, and others
Click to download

Audio Conference Call Part 1

Audio Conference Call Part 2

 

Supplementary materials for the financial statements: Underlying Core & Adjusted EBITDA Reconciliation
Click to download

FY2018 Q3 Results (released on February 14th, 2019)

Quarterly Securities Report (FY2018 Q3)
Click to download 

FY2018 Q3 Results (released on February 1, 2019)

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download

 

Data Book
Click to download


Earnings Release Presentation

1.Strategic Focus & Superior Execution FY2018 Q3 Results
Costa Saroukos, Chief Financial Officer
Click to download


2.Supplementary materials for the financial statements: Underlying Core & Adjusted EBITDA Reconciliation

Audio Conference Call Part 1

Audio Conference Call Part 2

37th Annual J.P. Morgan Healthcare Conference (Held on January 8, 2019 PST)

Presentation
J.P. Morgan Healthcare Conference Presentation
Click to download


Audio
・Conference call
・Q&A

*Link to J.P.Morgan website

Meeting regarding Acquisition of Shire plc by Takeda (Held on January 7th , 2019) 

Presentation
A Global, Values-based, R&D-driven Biopharmaceutical Leader
Click to download

Click here to see the video (for IR)

FY2018 Q2 Results (released on November 8th, 2018)

Consolidated Statement of Cash Flows
Click to download 

FY2018 Q2 Results (released on October 31, 2018)

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download

News Release

Data Book
Click to download


Earnings Release Presentation
For Media:
Strategic Focus & Superior Execution FY2018 Q2 Results

Christophe Weber, President & Chief Executive Officer
Click to download

For Investors & Analysts:
Strategic Focus & Superior Execution FY2018 Q2 Results
Christophe Weber, President & Chief Executive Officer
Andrew Plump, Chief Medical & Scientific Officer
Costa Saroukos, Chief Financial Officer
Click to download

 

Creating a Values based, R&D driven Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Click to download

Supplementary materials for the financial statements: Underlying Core Reconciliation
Click to download


Click here to listen to the Audio

Takeda’s R&D Investor Day (Boston) on October 11, 2018

Presentation
DELIVERING ON OUR R&D VISION

Andy Plump, Chief Medical and Scientific Officer

Click to download

Video
*Link to Digital Media Solutions’ website

Takeda’s R&D Investor Day (Tokyo) on September 27, 2018

Presentation
DELIVERING ON OUR R&D VISION

Andy Plump, Chief Medical and Scientific Officer

Click to download

Video
*Link to Nomura IR's website

FY2018 Q1 Results (released on August 10th, 2018)

Consolidated Statement of Cash Flows
Click to download 

FY2018 Q1 Results (released on July 31st, 2018)

Consolidated Financial Statements submitted to TSE(Tokyo Stock Exchange)
(Without Independent Auditor's report)
Click to download

Data Book
Partial correction of Data Book(September 11th,2018)
Click to download(After correction)


Earnings Release Conference Call
1. Consolidated Financial Results for FY2018 Q1
Costa Saroukos, Chief Financial Officer
Click to download

2. Supplemantary materials for the financial statements: Underlying Core Reconciliation
Click to download


Click here to listen to the Audio

Conference Call Regarding Proposed Acquisition of Shire plc by Takeda (Held on May 8/9, 2018)

Quarterly Results, Broker Conferences, Special IR Events Archive